Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioener...(leadership in key sectors said Tom Thor...)

Date:3/31/2009

leadership in key sectors," said Tom Thornton, President and CEO of KBA. "This was made possible by the teamwork of many players, including MRI, whose expertise in biosecurity, biosafety, and national laboratory management will be invaluable as we accelerate research efforts to protect the American food supply."

MRI plans to open its subsidiary office in the Manhattan/K-State Innovation Center in early April.

About Midwest Research Institute

MRI, a not-for-profit scientific research organization with 1,800 employees nationwide, performs contract research and laboratory consulting services for clients in government, industry, and academia. Established in 1944, MRI is one of the nation's leading independent research institutes conducting research in the areas of national security and defense, energy and environment, life sciences, food and agriculture, and transportation safety. With headquarters in Kansas City, MRI also has facilities in Palm Bay, Fla., Frederick, Md., and Rockville, Md. MRI is one of the two entities in the Alliance for Sustainable Energy, LLC, that manages and operates the National Renewable Energy Laboratory (NREL) in Golden, Colo., for the U.S. Department of Energy. For more information, visit www.mriresearch.org.

'/>"/>

SOURCE Midwest Research Institute Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
2. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
3. Center for Molecular Medicine One of the First Midwest Labs to Offer Advanced Test for Patients with Metastatic Breast Cancer
4. BioSpace Announces the 2008-2009 BioMidwest(TM) Hotbed Campaign
5. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
8. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
9. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
10. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
11. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience